Ruta Virsinskaite
Overview
Explore the profile of Ruta Virsinskaite including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Netti L, Ioannou A, Martinez-Naharro A, Razvi Y, Porcari A, Venneri L, et al.
Eur J Heart Fail
. 2024 Oct;
PMID: 39422337
Aims: Cardiac amyloidosis (CA) is characterized by deposition of amyloid fibrils within the extracellular space, causing disarray of the myocardial structure and capillary architecture. This study aims to characterize the...
2.
Porcari A, Masi A, Martinez-Naharro A, Razvi Y, Patel R, Ioannou A, et al.
JAMA Cardiol
. 2024 Aug;
9(11):982-989.
PMID: 39167388
Importance: Cardiac amyloid infiltration is the key determinant of survival in systemic light-chain (AL) amyloidosis. Current guidelines recommend early switching therapy in patients with a nonoptimal or suboptimal response regardless...
3.
Brown J, Virsinskaite R, Kotecha T, Steeden J, Fontana M, Karia N, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Aug;
25(12):1712-1720.
PMID: 39159164
Aims: Systemic sclerosis complicated by pulmonary arterial hypertension (SSc-PAH) is a rare condition with poor prognosis. The majority of patients are categorized as intermediate risk of mortality. Cardiovascular magnetic resonance...
4.
Jaubert O, Pascale M, Montalt-Tordera J, Akesson J, Virsinskaite R, Knight D, et al.
Sci Rep
. 2024 May;
14(1):11774.
PMID: 38783018
To develop and assess a deep learning (DL) pipeline to learn dynamic MR image reconstruction from publicly available natural videos (Inter4K). Learning was performed for a range of DL architectures...
5.
Knight D, Virsinskaite R, Karia N, Cole A, Maclean R, Brown J, et al.
Rheumatology (Oxford)
. 2024 May;
63(10):2678-2683.
PMID: 38759116
Objectives: Measures of right heart size and function are prognostic in systemic sclerosis-associated pulmonary hypertension (SSc-PH), but the importance of myocardial tissue characterisation remains unclear. We aimed to investigate the...
6.
Stubbs H, Cannon J, Knightbridge E, Durrington C, Roddis C, Gin-Sing W, et al.
BMJ Open Respir Res
. 2024 Mar;
11(1).
PMID: 38519115
Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to...
7.
Ioannou A, Nitsche C, Porcari A, Patel R, Razvi Y, Rauf M, et al.
J Am Heart Assoc
. 2024 Feb;
13(4):e033094.
PMID: 38314569
Background: Transthyretin cardiac amyloidosis (ATTR-CA) is a progressive and ultimately fatal cardiomyopathy. Biomarkers reflecting multiorgan dysfunction are of increasing importance in patients with heart failure; however, their significance in ATTR-CA...
8.
Ioannou A, Rauf M, Patel R, Razvi Y, Porcari A, Martinez-Naharro A, et al.
Eur J Heart Fail
. 2023 Nov;
26(1):65-73.
PMID: 37997196
Aims: Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy that commonly presents with concomitant chronic kidney disease. Albuminuria is common in heart failure and associated with worse outcomes, but its...
9.
Virsinskaite R, Karia N, Kotecha T, Schreiber B, Coghlan J, Knight D
Clin Med (Lond)
. 2023 Sep;
23(5):449-454.
PMID: 37775164
Pulmonary hypertension (PH) is common, with an estimated prevalence of approximately 1% that increases with age. Prompt and accurate diagnosis is key to institute timely and appropriate therapy to improve...
10.
Ioannou A, Patel R, Martinez-Naharro A, Razvi Y, Porcari A, Rauf M, et al.
JAMA Cardiol
. 2023 Jul;
8(9):848-852.
PMID: 37466990
Importance: Cardiac magnetic resonance (CMR) imaging-derived extracellular volume (ECV) mapping, generated from precontrast and postcontrast T1, accurately determines treatment response in cardiac light-chain amyloidosis. Native T1 mapping, which can be...